Recruiting NA Hematopoietic and Lymphoid System Neoplasm

New treatment option for Hematopoietic and Lymphoid System Neoplasm

Official title Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial

ClinicalTrials.gov ID: NCT06022965

What this study is testing

What it's testing
This clinical trial evaluates whether geriatric assessment-driven interventions with supportive care (GAIN-S) using telemedicine can be used to identify areas of vulnerability (weakness) in older adults with cancer and guide interventions to assist the patient and the healthcare team in the underserved community. The majority of patients diagnosed with cancer are over age 65 years, yet most cancer treatments are developed and tested in a younger population.
  • Time commitment: about 6 months
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 65 and older

You may be able to join if

  • Documented informed consent of the participant.
  • Patient's physician must agree for patient participation.
  • Ability to read English, Spanish, or Chinese. Other languages will be acceptable with site principal investigator (PI) agreement if surveys are...
  • Age: \>=65 years at the time of enrollment.
  • Diagnosis of stage I-IV cancer.

You likely can't join if

  • Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues...
See the full eligibility criteria
Who can join
  • Documented informed consent of the participant.
  • Patient's physician must agree for patient participation.
  • Ability to read English, Spanish, or Chinese. Other languages will be acceptable with site principal investigator (PI) agreement if surveys are available, and language does not preclude completing study procedures.
  • Age: \>=65 years at the time of enrollment.
  • Diagnosis of stage I-IV cancer.
  • Scheduled to start a new therapy (chemotherapy, immunotherapy, or targeted therapy).
What rules you out
  • Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics).

The study team makes the final eligibility decision.

Where it's taking place

  • Duarte, California, United States
  • Lancaster, California, United States
  • Upland, California, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Duarte, California, United States; Lancaster, California, United States; Upland, California, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.